-
Dac for "ARHGAP11A Maintains Cortical Progenitor Identity Through RHOA–ROCK Signalling During Human Brain Development" with Julia.ladewig@zi-mannheim.de, Department of Translational Brain Research. Moritz Mall, m.mall@dkfz-heidelberg.de, German Cancer Research Center (DKFZ). Yannick Hass, yannick.hass@zi-mannheim.de, Department of Translational Brain Research. Anne Hoffrichter, anne.hoffrichter@zi-mannheim.de, Department of Translational Brain Research, Central Institute of Mental Health
Dac
EGAC00001003603
-
CASCADE tumour high-coverage whole genome sequencing data
Dataset
EGAD00001009491
-
Circulating Biomarker Laboratory within the Division of Cancer of Imperial College London
Dac
EGAC50000000768
-
GeoMx digital spatial profiling of NGS mRNA expression in pre-treatment biopsies from patients.
Dac
EGAC50000000774
-
APC-related multiple salivary gland lesions
Study
EGAS50000001159
-
Germline WES-data of pediatric cancer patients with variants in HBOC-related genes
Study
EGAS50000001073
-
Michigan-Georgetown Cancer DAC
Dac
EGAC50000000397
-
IRCC
Dac
EGAC50000000068
-
scRNAseq + TCRseq of n-irAE patients
Study
EGAS50000000603
-
Neoantigens in bladder cancer
Dac
EGAC50000000740
-
The data access committee for "Validation of cfDNA fragmentome analyses for early detection of liver cancer"
Dac
EGAC00001003543
-
CRC and UC WES samples
Dac
EGAC50000000782
-
NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study
Study
phs004178
-
Intrapatient tumor heterogeneity and clonal evolution in metastatic salivary gland cancer: an autopsy study: access to data
Dac
EGAC50000000792
-
Dynamic Evolution of Fibroblasts Revealed by Single Cell RNA Sequencing of Human Pancreatic Cancer
Study
phs003751
-
A Therapeutic Vaccine for Fibrolamellar Hepatocellular Carcinoma
Study
phs003970
-
Single-cell Transcriptome Profiling of Treatment-naïve and Post-treatment Colorectal Cancer: Insights into Putative Mechanisms of Chemoresistance
Dac
EGAC50000000482
-
Cancer Research UK Manchester Institute/ Cancer Research UK National Biomarker Centre Data Access Committee
Dac
EGAC50000000795
-
Massachusetts General Hospital Cancer Center DAC for single cell RNA-seq data from small cell lung cancer primary tumors and CTCs
Dac
EGAC50000000808
-
Comprehensive genetic landscape, immune checkpoint profiling, and establishment of patient-derived xenograft (PDX) of metachronous brain tumors from constitutive mismatch repair deficiency with a biallelic variant on MSH6
Study
EGAS50000000351
-
Pan Prostate Cancer Group Data Access Control Committee
Dac
EGAC50000000602
-
Early-onset Colorectal Cancer Study TOGETHER Data Access Committee
Dac
EGAC50000000752
-
Division of Cancer Evolution National Cancer Center Research Institute Data Access Committee
Dac
EGAC50000000737
-
WGS of oesophagogastric cancer
Dac
EGAC50000000890
-
Liquid biopsy-based minimal residual disease monitoring for early risk stratification and decision-making in advanced non-small cell lung cancer
Dac
EGAC50000000832
-
DAC for lymphoma IFZ Essen
Dac
EGAC50000000521
-
Homologous recombination DNA repair deficiency and activity of PARP inhibition in primary triple negative breast cancer
Study
EGAS00001004190
-
Study on rectal mucus sampling for colorectal cancer diagnostics
Dac
EGAC50000000643
-
Whole genome sequencing to identify structural variants in early-stage breast cancer
Dac
EGAC50000000461
-
Data Access Committee for the DNA sequencing data included in the study "Multifocal cohort analysis unveils cell types associated with regional lymph node seeding in prostate cancer".
Dac
EGAC50000000930
-
Pan Prostate Cancer Group Data Access Control Committee
Dac
EGAC00001003628
-
COH/USC Ovarian Cancer Studies
Dac
EGAC50000000834
-
Methylation Biomarkers can Distinguish Pleural Mesothelioma from Healthy Pleura and other Pleural Pathologies
Study
EGAS00001008153
-
Somatic copy number alterations profiling in non-small cell lung cancer and their correlation with clinical efficacy in first-line treatment
Dac
EGAC50000000929
-
McGill Cancer Genetics Predisposition Data Access Committee
Dac
EGAC50000000954
-
RGB TGCT Data Access Committee
Dac
EGAC50000000959
-
Cancer Research UK Cambridge Institute
Dac
EGAC50000000683
-
DAC for CTOS colorectal cancer organoids
Dac
EGAC50000000915
-
WTCCC case-control study for Breast cancer
Study
EGAS00000000024
-
WTCCC case-control study for Breast cancer - Combined Controls
Study
EGAS00000000025
-
Single cell atlas of large B-cell lymphoma
Study
EGAS50000001022
-
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
Study
EGAS00000000054
-
Complex Landscapes of Somatic Rearrangements in Human Breast Cancer Genomes
Study
EGAS00000000062
-
Evolution of an adenomacarcinoma in response to selection by targeted kinase inhibitors
Study
EGAS00000000074
-
Fluctuating DNA methylation tracks cancer evolution at clinical scale
Study
EGAS50000001192
-
DHODH is a synthetic-lethal vulnerability in BCOR-deficient acute myeloid leukemia
Study
EGAS50000001060
-
Cancer Single Cell Sequencing
Study
EGAS00001000003
-
Lung_Rearrangement_Study
Study
EGAS00001000005
-
Renal_Cancer_Exome_Sequencing
Study
EGAS00001000006
-
Stabilising selection causes grossly altered but stable karyotypes in metastatic colorectal cancer
Study
EGAS00001004219
-
Shallow whole genome sequencing of ctDNA samples from DETECT study
Study
EGAS50000000911
-
CLL_cancer_Sample_Sequencing
Study
EGAS00001000011
-
Osteosarcoma_Sequencing
Study
EGAS00001000013
-
Error-corrected flow-based sequencing at whole genome scale and its application to circulating cell-free DNA profiling
Study
EGAS50000000844
-
Matched_breast_cancer_fusion_gene_study
Study
EGAS00001000031
-
Longitudinal single-cell RNA-seq data of metastatic ovarian cancer
Study
EGAS00001005010
-
Genomic and transcriptome analysis for intrahepatic cholangiocarcinoma
Study
EGAS00001006007
-
ADCC_Rearrangement_Screen
Study
EGAS00001000030
-
PV_Exome_Study
Study
EGAS00001000028
-
single cell RNA-seq of small cell lung cancer circulating tumor cells
Study
EGAS50000001401
-
Insights into BRCA1 and TP53 associated breast cancer development from integrated whole genome analysis of mouse model mammary tumors
Study
EGAS50000001402
-
MYC Inhibition By Omomyc Causes DNA Damage And Overcomes PARPi Resistance In Breast Cancer.
Study
EGAS50000001347
-
Single-Gene vs. Panel Sequencing in Advanced HR+/HER2− Breast Cancer
Study
EGAS00001008200
-
Multi-modal analysis of pediatric pilocytic astrocytomas reveals tumor location-associated cellular and transcriptional heterogeneity
Study
EGAS00001008187
-
Genomic analysis of HGSOC using long read sequencing
Study
EGAS50000001036
-
Pancreatic cancer RNA sequencing
Study
EGAS00001004706
-
Berlin Neuroblastoma Dataset
Study
EGAS00001004022
-
Case Report: Pre-Clinical Combination Targeting VEGF and PI3K in a Rare, Aggressive Mixed Endometrial Carcinoma
Study
EGAS50000001665
-
Resident memory CD8 T cell in human lung cancer
Study
EGAS00001004707
-
RNA sequencing of PTCL-NOS
Study
EGAS00001005015
-
PHRT study of longitudinal sampling in ovarian cancer
Study
EGAS50000001424
-
Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies
Study
EGAS00001003115
-
scRNAseq analysis of CD8 T cells infiltrating the bladder and tumor of 4 non-muscle-invasive bladder cancer patients, before and after BCG treatment.
Study
EGAS50000001384
-
WES analysis of paired tumor and non-tumoral DNA of 4 patients with non-muscle-invasive bladder cancer
Study
EGAS50000001382
-
bulk RNAseq analysis of tumor from 3 non-muscle-invasive bladder cancer patients
Study
EGAS50000001383
-
Variant analysis on FFPE specimen from NSCLC patients (OCAPlus)
Study
EGAS50000001136
-
Fragmentomics analyses of urinary cell-free DNA permit multi-urologic cancer detection and reduction in tissue biopsies for prostate cancer
Study
EGAS50000001431
-
NeoRhea Bulk RNA and Single nuclei RNA & ATAC
Study
EGAS50000001403
-
Transcriptomic profiling of patient-derived xenografts and organoids in prostate cancer
Study
EGAS00001004675
-
EXPRESSION OF ANTIBODY-DRUG CONJUGATE TARGETS IN BREAST CANCER METASTASES AND NORMAL TISSUE
Study
EGAS50000001334
-
Circulating kidney injury molecule-1 (KIM-1) and association with response to adjuvant immunotherapy in renal cell carcinoma
Study
EGAS50000001285
-
Ontario Institute for Cancer Research; Biliary Tract Cancer
Study
EGAS50000000972
-
The landscape of somatic mutations in epigenetic regulators across 1000 pediatric cancer genomes
Study
EGAS00001000449
-
Dual inhibition of FLT3 and BCL-2 is effective in preclinical models of BCL11B-activated lineage ambiguous leukemia
Study
EGAS50000000978
-
Genomic profiling of patient-derived xenografts and organoids in prostate cancer
Study
EGAS00001004673
-
Genomic evolution of pancreatic cancer at single-cell resolution
Study
EGAS50000001351
-
CAGEKID: Cancer Genomics of the Kidney
Study
EGAS00001000083
-
Single-cell RNA sequencing of metastatic colorectal cancer organoids treated with cetuximab
Study
EGAS50000001460
-
Whole genome sequencing of matched primary and metastatic acral melanomas
Study
EGAS00001000169
-
Genentech Colon Cancer Screen
Study
EGAS00001000288
-
Genetic landscape of pediatric Retinoblastoma
Study
EGAS00001000346
-
Error-Corrected Next-Generation Sequencing Rectal Mucus
Study
EGAS50000001398
-
A machine learning classifier for DNA repair defects using plasma DNA
Study
EGAS00001007006
-
DNA sequencing of sgRNAs enriched from the CRISPR-Cas9 screened HCC organoids
Study
EGAS50000001130
-
Adaptive Therapy Exploits Fitness Deficits in Chemotherapy-Resistant Ovarian Cancer to Achieve Long-Term Tumor Control Open Access
Study
EGAS50000001142
-
Bevacizumab plus erlotinib in advanced solid cancers with Krebs cycle gene mutations: A multicenter phase II study
Study
EGAS50000001243
-
Study of renal cancers and renal cancer metastases
Study
EGAS00001001176
-
Complex genotype-phenotype relationships shape the response to treatment of Down Syndrome Childhood Acute Lymphoblastic Leukaemia
Study
EGAS50000001287
-
Genetic differences between primary colorectal cancer and its paired synchronous and metachronous metastases
Study
EGAS50000000996
-
Circulating cell-free and extracellular vesicles-derived microRNA as prognostic biomarkers in patients with early-stage NSCLC: results from RESTING study
Study
EGAS50000001032